Clinical Trial Update: A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses of SAR438544 in Comparison to Placebo and Glucagon in Healthy Subjects and Type 1 Diabetes Mellitus Patients [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated safety, pharmacokinetics, and pharmacodynamics of escalating doses of SAR438544 compared with placebo and glucagon in healthy subje…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• SAR438544

Snippet

Sponsor: Sanofi | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED